Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Procaterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 16/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.98 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procaterol SCHEMBL30505289 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29390065 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL28926423 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL4633 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29445557 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL4632 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL124726 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29992718 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL9737339 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29832201 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080286349-A1 | SYSTEMS, DEVICES, AND METHODS FOR PASSIVE TRANSDERMAL DELIVERY OF ACTIVE AGENTS TO A BIOLOGICAL INTERFACE | ABRAMONTE, FRANK | 2008-11-20 | — | — | US | disclosed |
| US-20080286349-A1 | SYSTEMS, DEVICES, AND METHODS FOR PASSIVE TRANSDERMAL DELIVERY OF ACTIVE AGENTS TO A BIOLOGICAL INTERFACE | ABRAMONTE, FRANK | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286349-A1 | SYSTEMS, DEVICES, AND METHODS FOR PASSIVE TRANSDERMAL DELIVERY OF ACTIVE AGENTS TO A BIOLOGICAL INTERFACE | MMP1, CUTA, MMP8 | ADRB2 3496/4885ADRB1 3653/4885KDM4E 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.